Effect of Low-Fat Food on Pexidartinib Pharmacokinetics in Healthy Volunteers
NCT03901313
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
Treatment A - 400 mg Fasting
DRUG:
Treatment B - 400 mg Fed
DRUG:
Treatment C - 200 mg Fed
Sponsor
Daiichi Sankyo